Clinical trial
A Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects
NCT03253991 is registered in ClinicalTrials.gov with InSightec as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects
- Lead sponsor
- InSightec
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- November 17, 2014
- Completion date
- February 2, 2023
- Enrollment
- 154 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.